Validation of 24-Hour Fluconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Results from a Global Candida Antifungal Surveillance Program

被引:33
作者
Pfaller, M. A. [1 ,2 ]
Boyken, L. B. [1 ]
Hollis, R. J. [1 ]
Kroeger, J. [1 ]
Messer, S. A. [1 ]
Tendolkar, S. [1 ]
Diekema, D. J. [1 ,3 ]
机构
[1] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Epidemiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1128/JCM.01391-08
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We performed 24- and 48-h MIC determinations and disk diffusion testing of fluconazole against more than 11,000 clinical isolates of Candida species. By using the reference MIC breakpoints, the categorical agreement between the 24-h and reference 48-h broth microdilution results ranged from 93.8% (all Candida species) to 94.9% (all Candida species minus Candida krusei), with only 0.1% very major errors (VME). The essential agreement (within 2 log(2) dilutions) between the 24-h and 48-h results was 99.6%. The categorical agreement between the 24-h disk diffusion results and the 24-h MIC results, using the previously established breakpoints, was 94.4%, with 0.1% VME. Both the MIC and the disk diffusion results obtained for fluconazole after only 24 h of incubation may be used to determine the susceptibilities of Candida spp. to this widely used antifungal agent.
引用
收藏
页码:3585 / 3590
页数:6
相关论文
共 41 条
[1]  
[Anonymous], 2008, Approved standard M27-A. A National Committee for Clinical Laboratory Standards
[2]   Comparison of visual and spectrophotometric methods of broth microdilution MIC end point determination and evaluation of a sterol quantitation method for in vitro susceptibility testing of fluconazole and itraconazole against trailing and nontrailing Candida isolates [J].
Arthington-Skaggs, BA ;
Lee-Yang, W ;
Ciblak, MA ;
Frade, JP ;
Brandt, ME ;
Hajjeh, RA ;
Harrison, LH ;
Sofair, AN ;
Warnock, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2477-2481
[3]   Association of fluconazole pharmacodynamics with mortality in patients with candidemia [J].
Baddley, John W. ;
Patel, Mukesh ;
Bhavnani, Sujata M. ;
Moser, Stephen A. ;
Andes, David R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (09) :3022-3028
[4]   Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia [J].
Baddley, JW ;
Patel, M ;
Jones, M ;
Cloud, G ;
Smith, AC ;
Moser, SA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2004, 50 (02) :119-124
[5]  
Clinical and Laboratory Standards Institute, 2007, M44S2 CLIN LAB STAND
[6]  
Clinical Laboratory Standards Institute, 2008, M27S3 CLSI
[7]   To test or not to test:: A cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemias [J].
Collins, Curtis D. ;
Eschenauer, Gregory A. ;
Salo, Susan L. ;
Newton, Duane W. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (06) :1884-1888
[8]   Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species [J].
Cuenca-Estrella, M ;
Lee-Yang, W ;
Ciblak, MA ;
Arthington-Skaggs, BA ;
Mellado, E ;
Warnock, DW ;
Rodriguez-Tudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3644-3647
[9]   Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole itraconazole, posaconazole, and voriconazole for Candida spp.:: a collaborative study [J].
Espinel-Ingroff, A ;
Barchiesi, F ;
Cuenca-Estrella, M ;
Fothergill, A ;
Pfaller, MA ;
Rinaldi, M ;
Rodriguez-Tudela, JL ;
Verweij, PE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) :4535-4540
[10]   Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. [J].
Espinel-Ingroff, A ;
Pfaller, M ;
Messer, SA ;
Knapp, CC ;
Holliday, N ;
Killian, SB .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :718-721